FDA approves 1st new tuberculosis drug in 40 years

WASHINGTON — The Food and Drug Administration on Monday approved a Johnson &Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades.

The agency approved J&J’s pill, Sirturo, for use with older drugs to fight a hard-to-treat strain of tuberculosis that has not responded to other medications. However, the agency cautioned that the drug carries risks of potentially deadly heart problems and should be prescribed carefully by doctors.

Roughly one-third of the world’s population is estimated to be infected with the bacteria causing tuberculosis. The disease is rare in the U.S., but kills about 1.4 million people a year worldwide. Of those, about 150,000 succumb to the increasingly common drug-resistant forms of the disease. About 60 percent of all cases are concentrated in China, India, Russia and Eastern Europe.

Sirturo, known chemically as bedaquiline, is the first medicine specifically designed for treating multidrug-resistant tuberculosis. That’s a form of the disease that cannot be treated with at least two of the four primary antibiotics used for tuberculosis.

The standard drugs used to fight the disease were developed in the 1950s and 1960s.

“The antibiotics used to treat it have been around for at least 40 years and so the bacterium has become more and more resistant to what we have,” said Chrispin Kambili, global medical affairs leader for J&J’s Janssen division.

The drug carries a boxed warning indicating that it can interfere with the heart’s electrical activity, potentially leading to fatal heart rhythms.

“Sirturo provides much-needed treatment for patients who have don’t have other therapeutic options available,” said Edward Cox, director of the FDA’s antibacterial drugs office. “However, because the drug also carries some significant risks, doctors should make sure they use it appropriately and only in patients who don’t have other treatment options.”

Nine patients taking Sirturo died in company testing compared with two patients taking a placebo. Five of the deaths in the Sirturo group seemed to be related to tuberculosis, but no explanation was apparent for the remaining four.

Despite the deaths, the FDA approved the drug under its accelerated approval program, which allows the agency to clear innovative drugs based on promising preliminary results.

Last week, the consumer advocacy group Public Citizen criticized that approach, noting the drug’s outstanding safety issues.

“The fact that bedaquiline is part of a new class of drug means that an increased level of scrutiny should be required for its approval,” the group states. “But the FDA had not yet answered concerns related to unexplained increases in toxicity and death in patients getting the drug.”

The FDA said it approved the drug based on two mid-stage studies enrolling 440 patients taking Sirturo. Both studies were designed to measure how long it takes patients to be free of tuberculosis.

Results from the first trial showed most patients taking Sirturo plus older drugs were cured after 83 days, compared with 125 days for those taking a placebo plus older drugs. The second study showed most Sirturo patients were cured after 57 days.

More in Herald Business Journal

Everett engineers learn lessons from Mexico City catastrophe

Structural scientists went to help after the September earthquake there and studied the damage.

DaVita to sell off medical groups including The Everett Clinic

Another round of health care consolidation means The Everett Clinic could soon get new ownership.

Engine trouble hits Air New Zealand’s 787 Dreamliners

A Rolls-Royce engine was shut down and was afterward found to be seriously damaged.

The Marine Corps’ version of the F-35 Joint Strike Fighter is designed to land vertically like a helicopter. (Lockheed Martin)
F-35 fighter costs, $1 trillion over 60 years, draw scrutiny

Pentagon’s ability to repair F-35 parts at military depots is six years behind schedule.

Incidents of severe disturbances on commercial flights climb

The number of cases in which the cabin crew had to restrain a passenger rose to 169 last year.

Funko mascots Freddy Funko roll past on a conveyor belt in the Pop! Factory of the company’s new flagship store on Aug. 18, 2017. (Dan Bates / The Herald)
Funko starts to bounce back after disappointing stock debut

The Everett toys-and-collectibles maker also announced the acquisition of an animation studio.

Now hiring: Younger factory workers, at Boeing and elsewhere

The company and its training partners are fighting perceptions of a dying manufacturing industry.

‘The President Stole Your Land’: Patagonia, REI blast Trump

The outdoor recreation industry is allied with Indian tribes and conservationists.

A recruiter from a driller in the shale gas industry (left), speaks with an attendee at a job fair in Cheswick, Pennsylvania, in November. (AP Photo/Keith Srakocic)
A stronger global economy is helping boost the US job market

In November, U.S. employers added a substantial 228,000 jobs, the Labor Department says.

Most Read